Adjuvant therapy of stage II breast cancer: 48-month follow-up of a prospective randomized clinical trial.
Hubay CA, Pearson OH, Marshall JS, Stellato TA, Rhodes RS, DeBanne SM, Rosenblatt J, Mansour EG, Hermann RE, Jones JC, Flynn WJ, Eckert C, McGuire WL.
Hubay CA, et al. Among authors: stellato ta.
Breast Cancer Res Treat. 1981;1(1):77-82. doi: 10.1007/BF01807895.
Breast Cancer Res Treat. 1981.
PMID: 6756509
Clinical Trial.